SRSF1-3 contributes to diversification of the immunoglobulin variable region gene by promoting accumulation of AID in the nucleus by Kawaguchi, Yuka et al.
 
SRSF1-3 contributes to diversification of the immunoglobulin variable region gene by 
promoting accumulation of AID in the nucleus 
 
Yuka Kawaguchi, Hiroaki Nariki, Naoko Kawamoto, Yuichi Kanehiro1, Satoshi Miyazaki, 
Mari Suzuki, Masaki Magari, Hiroshi Tokumitsu, Naoki Kanayama* 
 
Department of Medical Bioengineering, Graduate School of Natural Science and Technology, 
Okayama University, 3-1-1 Tsushima-naka, Kita-ku, Okayama 700-8530, Japan. 
 
* Corresponding author. FAX: +81-86-251-8198 
E-mail: nkanayam@okayama-u.ac.jp (N. Kanayama) 
 
1 Present address: Department of Microbiology and Immunology, Shimane University School of 
Medicine, Izumo, Shimane 693-8501, Japan 
 
Abbreviations: AID, activation-induced cytidine deaminase; AIDDC, C-terminal 10 amino acid-
deleted AID; CSR, class switch recombination; GCV, gene conversion; IgV, immunoglobulin 
variable region; NES, nuclear export signal; SHM, somatic hypermutation; SRSF1, serine-
arginine protein splicing factor 1. 
  
 
ABSTRACT 
Activation-induced cytidine deaminase (AID) is essential for diversification of the Ig variable 
region (IgV). AID is excluded from the nucleus, where it normally functions. However, the 
molecular mechanisms responsible for regulating AID localization remain to be elucidated. The 
SR-protein splicing factor SRSF1 is a nucleocytoplasmic shuttling protein, a splicing isoform of 
which called SRSF1-3, has previously been shown to contribute to IgV diversification in chicken 
DT40 cells. In this study, we examined whether SRSF1-3 functions in IgV diversification by 
promoting nuclear localization of AID. AID expressed alone was localized predominantly in the 
cytoplasm. In contrast, co-expression of AID with SRSF1-3 led to the nucleus accumulation of 
both AID and SRSF1-3 and the formation of a protein complex that contained them both, although 
SRSF1-3 was dispensable for nuclear import of AID. Expression of either SRSF1-3, or a C-
terminally-truncated AID mutant increased IgV diversification in DT40 cells. However, 
overexpression of exogenous SRSF1-3 was unable to further enhance IgV diversification in DT40 
cells expressing the truncated AID mutant, although SRSF1-3 were able to form a protein complex 
with the AID mutant. These results suggest that SRSF1-3 promotes nuclear localization of AID 
probably by forming a nuclear protein complex, which might stabilize nuclear AID and induce IgV 
diversification in an AID C-terminus-dependent manner. 
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1. Introduction 
Germinal center B cells express activation-induced cytidine deaminase (AID), which converts 
dC to dU on single-stranded (ss) DNAs to allow somatic hypermutation (SHM) on the Ig variable 
region genes (IgV) and class switch recombination (CSR) on Ig constant region genes, during 
antibody affinity maturation [1, 2]. The expression and activity of AID are regulated through a 
multi-layered process, including regulation of subcellular localization (reviewed in [3] ). AID is 
predominantly localized in the cytoplasm by nuclear exclusion and cytoplasmic retention. 
However, the molecular mechanisms that shuttle AID between the cytoplasm and the nucleus have 
not been fully elucidated. 
The chicken B cell line DT40 constitutively expresses AID, and somatic hypermutation (SHM) 
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and another IgV-diversifying process, gene conversion (GCV), both of which are initiated by a 
common intermediate, occur spontaneously in DT40 cells [4, 5]. We previously found an important 
role for a splice variant of the serine/arginine (SR)-rich protein splicing factor 1 (SRSF1), referred 
to here as SRSF1-3, in SHM and GCV [6]. An engineered DT40 cell line, DT40-ASF, in which 
the endogenous SRSF1 gene is disrupted and the human SRSF1 cDNA is expressed [7], was unable 
to induce SHM and GCV, whereas introduction of SRSF1-3 into the DT40-ASF cells restored 
these IgV diversification events [6]. The prototypical SR protein, SRSF1 (formerly ASF/SF2), is a 
nucleocytoplasmic shuttling protein, which is not only essential for RNA splicing but also has a 
variety of roles in RNA metabolism [8].  
SRSF1-3 is an alternatively spliced product of SRSF1, which shares the N-terminal region with 
SRSF1 but contains an alternate C-terminus [9]. Since the alternate C-terminus is not conserved 
between species, and does not include any other characteristic protein motifs that indicate its 
function, the molecular role of SRSF1-3 in IgV diversification remains unknown. Recently, several 
transcription-coupled factors have been shown to associate with AID, thereby forming a protein 
complex that induces SHM and CSR (reviewed in [3]). It has also been reported that AID co-
localizes with splicing factors in sub-nuclear domains where SRSF1 is predominantly enriched 
[10]. The increase in the number of reports connecting AID and SRSF1 prompted us to explore 
whether SRSF1-3, an isoform of SRSF1, contributes to the nuclear localization of AID. In this 
study, we investigated a role for SRSF1-3 in the subcellular localization of AID using fluorescently 
tagged fusion proteins. The results suggest that SRSF1-3 promotes accumulation of AID in the 
nucleus during IgV diversification. 
 
 
2. Materials and methods 
 
2.1. Cell lines 
 
Wild-type DT40 cells and 293T cells were obtained from the RIKEN Cell Bank. DT40-ASF 
cells [7], DT40-SW cells [11], and DT40-SWDC cells [12] were described previously. DT40 cells 
were cultured as described previously [11]. 293T cells were cultured in DMEM (Life Technologies, 
Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum and 50 µM 2-
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mercaptoethanol at 37°C in 5% CO2 
 
2.2. Construction of expression vectors and transfection 
 
The FLAG-tagged chicken SRSF1-3 (FLAG-SRSF1-3) expression vector has been described 
previously [6]. An mCherry DNA fragment excised from the pmCherry-C1 vector (Clontech 
Laboratories, Mountain View, CA, USA) was inserted in frame just upstream of the FLAG-
SRSF1-3 in the FLAG-SRSF1-3 expression vector. A Myc-tagged chicken AID cDNA fragment 
and its C-terminus truncated version were generated from a chicken AID cDNA clone [11] by PCR, 
and cloned into the pCI-bsr vector [13]. An AID cDNA fragment generated by PCR was fused in 
frame with a DNA fragment encoding EGFP, derived from the pEGFP-N1 vector (Clontech 
Laboratories), in the pCI-bsr vector. PCR was carried out using KOD FX neo DNA polymerase 
(Toyobo, Osaka, Japan) and primers listed in Supplemental Table 1, and the nucleotide sequences 
of all PCR-cloned fragments were confirmed by sequencing analysis. 
293T cells were transiently transfected with expression vectors using the X-treme GENE HP 
DNA transfection reagent (Roche Diagnostics, Mannheim, Germany). The pCI-bsr vector was 
used as a mock vector. DT40 cells were transfected with expression vectors by electroporation 
using the Neon Transfection System (Invitrogen/Thermo Fisher Scientific, Waltham, MA, USA), 
and selected in a medium containing 20 µg/mL Blasticidin S (Kaken Pharmaceutical, Tokyo, 
Japan). 
 
2.3. Microscopic analysis 
 
Transfected 293T cells, which had been cultured on cover slips coated with 0.1% gelatin, and 
DT40 cells were fixed with 4% paraformaldehyde for 15 min, permeabilized in 0.1% Triton X-
100/PBS, and mounted on slide glasses with ProLong® Gold Antifade Reagent with DAPI 
(Invitrogen). In some experiments, DT40 cells were treated with 10 µM MG132 (Sigma-Aldrich, 
St. Louis, MO, USA) and 10 ng/mL Leptomycin B (Cayman Chemical, Ann Arbor, MI, USA) for 
6 h and 2 h, respectively. 
Cell images were acquired using an FV1000 confocal laser-scanning microscope equipped with 
objective lenses, UPlanSApo 60× or UPlanFLN 40× (Olympus) with immersion oil, and FluoView 
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software (Olympus, Tokyo, Japan). Cells that showed bright GFP and/or mCherry fluorescence 
were selected for analysis in each microscopic view under conditions where the gain of each 
detector and the power of each laser were adjusted to minimize crosstalk detection between 
channels. The mean fluorescence intensity (MFI) of AID-GFP in the nuclear and cytoplasmic 
regions of interest in chosen cells was quantified using ImageJ software (NIH, Bethesda, MD, 
USA). Regions, which corresponded to AID-GFP or DNA, were considered as representing the 
whole cell or the nucleus of each cell, respectively. The MFI of AID-GFP in the cytoplasmic region 
of each cell was calculated by subtracting that in the nuclear region from that in the whole cell 
region. The subcellular localization of AID-GFP was evaluated by calculating the ratio of the MFI 
of AID-GFP in the nuclear region over that in the cytoplasmic region.  
 
2.4. Subcellular fractionation and western blotting 
 
The nuclear and cytoplasmic fractions of transfected 293T cells were separated with the NE-
PER Nuclear and Cytoplasmic Extraction Kit (Thermo Fisher Scientific/Pierce Biotechnology, 
Rockford, IL, USA). Whole cell lysates were prepared by sonicating cells in the Laemmli sample 
buffer with a Bioruptor UCD-250 (Cosmo Bio, Tokyo, Japan). Samples were subjected to SDS-
PAGE and transfer onto PVDF membranes (Immobilon P; Millipore, Billerica, MA, USA), and 
probed with antibodies listed in Supplemental Table 2. Blots were developed using Western 
Lightning Plus-ECL (PerkinElmer, Waltham, MA, USA), and chemiluminescence was detected 
using the ChemiDoc XRS system (Bio-Rad Laboratories, Hercules, CA, USA). The intensity of 
each signal was quantified with Quantity One software (Bio-Rad Laboratories). 
 
2.5 Immunoprecipitation 
 
Cell-free extracts of transfected 293T cells were prepared by disrupting cells with a Bioruptor 
sonicator in the presence of a protease inhibitor mixture (Nakalai Tesque, Kyoto, Japan), and by 
centrifugation. An aliquot of cell-free extracts was used as an input control. Anti-FLAG mAb (M2, 
Sigma-Aldrich) was adsorbed on Dynabeads™ Protein G magnetic beads (Invitrogen) using a 30-
min incubation at room temperature, and the mAb-immobilized magnetic beads were then 
incubated with cell-free extracts at 4°C for 1 h. After washing the beads, proteins bound to the 
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beads were analyzed by western blotting using antibodies (Supplemental Table 2) and Western 
Lightning Pro ECL (PerkinElmer) to detect signals at a higher sensitivity. 
 
2.6 Analysis of IgV diversification 
 
The SRSF1-3 expression vector was introduced into DT40-SW and DT40-SWDC cells as 
described previously [6]. The transcription level of the SRSF1-3 gene was determined by 
quantitative RT-PCR using the GAPDH gene as a control, as described previously [6]. AID 
expression in these cell lines can be reversibly switched on or off by 4-hydroxytamoxyfen (4-
OHT) treatment [11]. GCV frequency in these cell lines was evaluated using a G/B construct as an 
artificial GCV substrate, which was integrated into the un-rearranged IgVL allele, as described 
previously [6, 13]. After 4-OHT treatment, single AID-expressing cells were sorted into culture 
plates using a FACS Aria equipped with Auto Cell Deposit Unit (BD Biosciences, San Diego, CA, 
USA), and maintained for weeks. The frequency of cells developing a strong green fluorescence 
signal was analyzed using FACS Array (BD Biosciences). The nucleotide sequence analysis of the 
IgVH gene was carried out after 3-week cultures of DT40-SW cells and DT40-SWDC cells, with 
or without overexpression of SRSF1-3, as described previously [6, 12].  
 
2.7 Statistical analyses 
 
Statistical analyses were carried out using GraphPad Prism software (GraphPad Software, La 
Jolla, CA, USA). The unpaired two-tailed Student’s t test was performed to evaluate statistically 
significant differences between two groups. The Pearson correlation analysis was performed to 
calculate correlation coefficients. The chi-square test was performed to evaluate difference in the 
mutation frequency of the IgV gene between two groups. Probability (p) values: *, p < 0.05; **, p 
< 0.01; ***, p < 0.001; ****, p < 0.0001; ns, not significant. 
 
 
3. Results 
3.1 Co-expression of AID with SRSF1-3 promotes the accumulation of AID in the nucleus 
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To visualize the subcellular localization of AID and SRSF1-3, chicken AID tagged with GFP at 
the C-terminus (AID-GFP) and chicken SRSF1-3 tagged with mCherry at the N-terminus 
(mCherry-SRSF1-3) were transiently expressed in human 293T cells. The subcellular localization 
of these fluorescent fusion proteins in these cells was then observed by confocal microscopy. When 
AID-GFP was expressed alone, i.e., without exogenous expression of SRSF1-3, AID-GFP was 
found predominantly in the cytoplasm in 293T cells (Fig. 1A) [14, 15]. Interestingly, when AID-
GFP was co-expressed with mCherry-SRSF1-3 in 293T cells, AID-GFP levels increased in the 
nuclear compartment (Fig. 1A). The proportion of the nucleus AID-GFP was significantly higher 
in cells co-expressing AID-GFP and mCherry-SRSF1-3 than in cells expressing AID-GFP alone 
(Fig. 1B). In addition, the nuclear localization of AID-GFP was positively correlated with the mean 
fluorescence intensity of co-expressed mCherry-cSRSF1-3 (Fig. 1C). It should be noted that AID 
tended to be co-localized with SRSF1-3 in both the nucleus and the cytoplasm (Fig. 1A). In 
addition, subcellular fractionation analysis of 293T cells expressing Myc-tagged AID (Myc-AID) 
and FLAG-tagged chicken SRSF1-3 (FLAG-SRSF1-3) without fluorescent protein tags also 
confirmed that co-expression of AID with SRSF1-3 significantly enhanced accumulation of AID 
in the nuclear fraction in a fluorescent tag-independent manner (Fig. 2A). Taken together, these 
results reveal that SRSF1-3 promotes accumulation of AID in the nucleus. 
We next wished to explore whether SRSF1-3 contributes to the nucleus accumulation of AID 
through interaction with AID as is seen for other transcription-coupled factors. The interaction 
between AID and SRSF1-3 was examined by co-immunoprecipitation experiments. When Myc-
AID was co-expressed with FLAG-SRSF1-3 in 293T cells, Myc-AID was co-immunoprecipitated 
with FLAG-SRSF1-3 using an anti-FLAG mAb from cell lysates (Fig. 2B), suggesting that AID 
and SRSF1-3 are found in the same protein complex. 
 
3.2 SRSF1-3 is dispensable for the import of AID into the nucleus 
 
AID proteins imported from the cytoplasm into the nucleus are immediately re-exported or 
degraded [16, 17]. Thus, at steady state, AID proteins appear to be mostly in the cytoplasm. We 
next examined whether SRSF1-3 could promote the import of AID into the nucleus. We generated 
cell lines stably expressing the AID-GFP fusion protein in SRSF1-3-sufficient wild-type DT40 
cells and SRSF1-3-deficient DT40-ASF cells, which are competent and incompetent in IgV 
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diversification, respectively [6]. In contrast to the results of the transient co-expression 
experiments in 293T cells (Fig. 1), AID was observed predominantly in the cytoplasm either in the 
presence or absence of SRSF1-3 expression in these DT40 lines (Fig. 3A, upper panels). This is 
probably due to the immediate degradation and/or nuclear re-export of the imported AID. When 
both proteasomal protein degradation and protein export from the nucleus were inhibited by 
treating these cells with specific inhibitors, MG132 and Leptomycin B, respectively, the treatment 
with both inhibitors resulted in the increased accumulation of AID in the nucleus, both in the 
presence and absence of SRSF1-3 (Fig. 3A, lower panels, and 3B), suggesting that SRSF1-3 is 
dispensable for the nuclear import. 
 
3.3 A role for SRSF1-3 in IgV diversification might depend on the C-terminus of AID 
 
The C-terminus of AID is involved in several molecular processes during IgV diversification. 
Deletion of the C-terminus, including a nuclear export signal (NES), leads to not only 
accumulation of AID proteins in the nucleus [14, 15], but also enhanced SHM and GCV on the 
IgV gene [12, 18]. Similarly, overexpression of SRSF1-3 can promote nuclear accumulation of 
AID (Fig. 1) and in addition enhance SHM and GCV frequency in DT40 cells [6]. Thus, we 
examined whether SRSF1-3 could contribute to SHM and GCV cooperatively or independently 
through functions associated with the AID C-terminus.  
DT40 cell lines that express the wild-type AID and a C-terminally-truncated (10 amino acids) 
mutant (AIDDC), respectively, were previously established [11, 12]. Stable SRSF1-3-
overexpressing lines were generated from these cell lines (Fig. 4A). An artificial DNA substrate 
encoding blue and green fluorescent proteins was introduced into the IgVL locus of DT40 cells 
[13]. In these cell lines, a GCV event in each cell can be monitored as the change of fluorescence 
color from blue to green. Thus, cells in which GCV occurred were observed by flow cytometry as 
GFPhi cells (Fig. 4B). In the wild-type AID-expressing DT40 cells, overexpression of SRSF1-3 
resulted in a significantly higher GCV frequency compared with the control cells without SRSF1-
3 overexpression as reported previously [6]. AIDDC-expressing DT40 cells showed a higher GCV 
frequency than the wild-type control as described previously [12]. In contrast, overexpression of 
SRSF1-3 in AIDDC-expressing cells was unable to enhance GCV frequency.  
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To confirm the results using the artificial GCV substrate, nucleotide sequences of the Ig heavy 
chain variable region (IgVH) gene were analyzed after 3-week cultures of the wild-type AID or 
AIDDC-expressing DT40 cells, with or without overexpression of SRSF1-3 (Fig. 4C). A 
significant number of mutations accumulated in the IgVH gene in AIDDC-expressing DT40 cells 
without overexpression of SRSF1-3, compared with the wild-type AID-expressing DT40 cells. 
However, overexpression of SRSF1-3 did not affect IgVH mutation frequency in AIDDC-
expressing DT40 cells (Fig. 4C), whereas it resulted in an significant increase in the mutation 
frequency in the wild-type AID-expressing cells. These data reveal that SRSF1-3 may function 
cooperatively through an AID C-terminus-dependent mechanism 
Finally, to examine whether SRSF1-3 affects AID function through a direct protein interaction 
with the AID C-terminus, we carried out immunoprecipitation experiments using FLAG-SRSF1-
3, and Myc-tagged wild-type AID or AIDDC. As is the case for wild-type Myc-AID, Myc-AIDDC 
was also co-precipitated with FLAG-SRSF1-3 despite the absence of the AID C-terminus (Fig. 
4D), demonstrating that SRSF1-3 can form a protein complex with AID in an AID C-terminus-
independent manner. 
 
 
4. DISCUSSION 
 
In the present study, overexpression of SRSF1-3 revealed that SRSF1-3 may induce nuclear 
accumulation of AID and promote IgV diversification in an AID C-terminus-dependent manner. 
SRSF1-3 formed a protein complex with AID, even in the absence of the AID C-terminus, as has 
been reported for other transcription-coupled factors that are responsible for SHM and CSR 
(reviewed in [3]), and furthermore SRSF1-3 and AID have been previously shown to be recruited 
to the IgV gene [6]. Thus, we propose that SRSF1-3 may be involved in the formation and 
maintenance of a stable transcription-coupled protein complex responsible for inducing IgV gene 
diversification in the nucleus.  
 
The present experiments using fluorescently tagged proteins indicated that AID-GFP appeared 
to be excluded from the nucleus in 293T cells and DT40 cells that might express a low level of 
endogenous SRSF1-3 (Fig. 1A and 3A) [6]. The nuclear exclusion of AID is due to both nuclear 
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export and protein degradation, since this localization was sensitive to Leptomycin B and MG132 
treatment. Although endogenous SRSF1-3 may contribute to the accumulation of AID, the protein 
level of AID is kept very low in the nucleus at steady state partly because the level of endogenous 
SRSF1-3 is very low in DT40 cells [6]. In addition, particularly in hyper-mutating cells such as 
DT40 cells and human Ramos cells, AID is excluded from the nucleus even in the absence of 
nuclear export of AID because of accelerated proteasomal degradation [12, 16]. This proteasomal 
degradation of AID in these hypermutating cells may be induced in an AID deaminase activity-
dependent manner [19]. Overexpressed SRSF1-3 may manifest a role for endogenous SRSF1-3 in 
the nuclear accumulation of AID by competing with intra-nuclear processes, including nuclear 
export and proteasomal degradation of AID.  
 
SRSF1 is a nucleocytoplasmic shuttling protein, which moves across the nuclear membrane pore, 
along with a number of other proteins and mRNAs, as large ribonucleoprotein complexes [8]. 
Because the RS domain at the C-terminus of SRSF1 is not required for nuclear import of SRSF1 
[20], it could be presumed that SRSF1-3, which lacks the RS domain, might contribute to the 
nuclear import of AID as a transportation carrier through an interaction with AID (Fig. 2B). 
However, this is unlikely because AID was able to localize to the nucleus even in the absence of 
SRSF1-3 (Fig. 3), although a supporting role for SRSF1-3 in nuclear import cannot be excluded. 
In addition, the AID molecule has its own nuclear import signal, which enables AID to move into 
the nucleus through an importin-mediated mechanism [3].  
 
Whereas expression of either SRSF1-3 or AIDDC was able to increase the nuclear localization 
of AID and thus the frequency of SHM and GCV, co-expression of both molecules did not show 
any additive effects on SHM and GCV (Fig. 4). Thus, SRSF1-3 might function cooperatively with 
AID at the C-terminus of AID. However, since AID∆C can form a protein complex with SRSF1-
3, this cooperation may not be mediated through a direct interaction with the AID C-terminus (Fig. 
4). Deletion of the AID C-terminus results in decreased CSR but intact SHM, implying that the C-
terminus of AID might have a role in determining which mechanism, either CSR or SHM, AID is 
engaged in [12, 14, 18]. Thus, SRSF1-3 may have a role in the nuclear accumulation of AID or in 
the activation of AID by an indirect interaction with the AID C-terminus in a protein complex 
containing AID and SRSF1-3, e.g., through regulating other factors that associate with the AID C-
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terminus. Further investigations into the roles of SRSF1-3 will reveal whether SRSF1-3 
contributes to the regulation of other intra-nuclear processes to induce AID-dependent IgV 
diversification. 
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Figure legends 
 
FIGURE 1. Co-expression of AID with SRSF1-3 promotes accumulation of AID in the 
nucleus. 
(A) AID accumulates in the nucleus in the presence of overexpressed SRSF1-3. The localization 
of the fusion proteins in 293T cells was observed by confocal microscopy 36 h after transfection 
with the AID-GFP expression vector alone, or with expression vectors encoding AID-GFP and 
mCherry-SRSF1-3. The scale bar represents 10 µm. (B) The subcellular localization of AID was 
evaluated by calculating the ratio of nuclear AID-GFP over cytoplasmic AID-GFP in individual 
cells, as described in Materials and methods. The horizontal bar indicates the median of the ratio 
values for each sample group. (C) A correlation analysis for the nuclear localization of AID and 
the level of SRSF1-3 expression. The value for AID localization in each cell shown in panel B was 
plotted against the mean fluorescent intensity (MFI) of total mCherry-cSRSF1-3 in each cell. The 
MFI value was expressed as an arbitrary unit (A.U.).  
 
FIGURE 2. Biochemical analyses of cells co-expressing AID with SRSF1-3. 
(A) Co-expression of AID with SRSF1-3 increases AID in the nuclear fraction. The cytoplasmic 
and nuclear fractions of non-transfected 293T cells and transiently transfected cells expressing 
Myc-AID (AID) and FLAG-SRSF1-3 (SRSF1-3) or Myc-AID alone were analyzed by western 
blotting using anti-AID and anti-FLAG (SRSF1-3) mAbs. Hsp90 and acetylhistone H4 were used 
as internal controls for the cytoplasmic and nuclear fractions, respectively. The ratio of the nuclear 
 
AID signal over the cytoplasmic AID signal was calculated (lower panel). The horizontal bar 
indicates the mean of the ratio values for three independent experiments. (B) SRSF1-3 forms a 
protein complex with AID. Protein complexes containing FLAG-SRSF1-3 were 
immunoprecipitated using an anti-FLAG mAb from cell lysates of 293T cells transiently 
expressing Myc-AID and the FLAG-SRSF1-3 or Myc-AID alone, and analyzed by western 
blotting using anti-Myc (AID) and anti-FLAG (SRSF1-3) mAbs. Asterisks indicate the L chain of 
the anti-FLAG mAb. Data are representative of three independent experiments. 
 
FIGURE 3. SRSF1-3 is dispensable for nuclear import of AID. 
(A) AID accumulates in the nucleus of DT40 cells, in the presence or absence of SRSF1-3, 
following inhibition of both protein degradation and nuclear export. SRSF1-3-sufficient (DT40-
WT) and SRSF1-3-deficient (DT40-ASF) DT40 cells stably expressing AID-GFP were treated 
with MG132 (6 h) and Leptomycin B (2 h), prior to confocal microscopic analysis. The scale bar 
represents 10 µm. Data are representative of two independent experiments. (B) The subcellular 
localization of AID in DT40 cells treated or untreated with both MG132 and Leptomycin B was 
quantitated by calculating the ratio of nuclear AID-GFP over cytoplasmic AID-GFP in individual 
cells, as described in Fig. 1. 
 
FIGURE 4. A role for SRSF1-3 in IgV diversification depends on the C-terminal region of 
AID. 
(A) The transcript levels of SRSF1-3 in DT40 cells expressing either a wild-type AID (AID-WT) 
or a C-terminally-deleted AID (AIDDC), with or without overexpression of SRSF1-3, were 
analyzed by qRT-PCR. Bars are means of triplicate assays. (B) Overexpression of SRSF1-3 does 
not further enhance GCV activity in AIDDC-expressing DT40 cells. BFP+ (GCV-un-induced) 
single DT40 cells (n = 19 or 20) expressing the wild-type AID or AIDDC, with or without 
overexpression of SRSF1-3, were cultured for 2 weeks. GFPhi (GCV-induced) cells were counted 
by flow cytometry. The horizontal bar indicates the median of GFPhi cell proportions for each 
sample group. (C) The nucleotide sequence analysis of the IgVH genes of DT40 cells expressing 
wild-type AID or AIDDC, with or without overexpression of SRSF1-3, after 3-week culture. The 
segment sizes in pie charts show the proportion of sequences with 0-9 mutations. (D) SRSF1-3 
forms a protein complex with AID∆C. Immunoprecipitation was carried out as described in Fig. 
 	
2B. Asterisks indicate the L chain of the anti-FLAG mAb. Data are representative of three 
independent experiments. 


•  SRSF1-3 promotes the nuclear accumulation of AID. 
•  SRSF1-3 forms a protein complex with AID in an AID C-terminus-independent manner. 
•  SRSF1-3 contributes to IgV hypermutation in an AID C-terminus-dependent manner. 
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Supplemental Table 1.
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Supplemental Table 2.  Primers used for PCR and qRT-PCR in this study.
Primer Sequence (5’ to 3’) Reference
Construction for the Myc-AID expression vector
myctagcAID (sense) GGAATTCGCCACCATGGAGCAGAAACTCATCTC- This study
TGAAGAGGATCTGGGCATGGACAGCCT
AID4 (antisense) CTCCTTTCTTGGCTGGGTGAGAGGTCCATA [1]
Construction for the Myc-AID∆C expression vector
cAIDdc-r (antisense) CTGATGAATTCCTCTTCAATCATCTAC This study
Construction for the Myc-AID-EGFP expression vector 
AID-kp-r (antisense) CTTCCGGTACCAGTCCCAGAGTTTTAAAGGCATC This study
Quantitate RT-PCR
For the SRSF1-3 transcript
cASF F1-Q GTACAGAGTGATCGTCTCGGGG [2]
cASF3-R3-Q CTGGCCAAAACCAAGTAAGCG [2]
For the GAPDH transcript
cgapdh-f GAGGTGCTGCCCAGAACATCATC [2]
cgapdh-r CCCGCATCAAAGGTGGAGGAAT [2]
Mutation analysis of the IgVH gene
cvh1f2 GGCGGCTCCGTCAGCGCTCTCT [2]
cjh1r2 GCCGCAAATGATGGACCGAC [2]
[1] H. Arakawa, J. Hauschild, J.-M. Buerstedde, Requirement of the activation-induced deaminase 
(AID) gene for immunoglobulin gene conversion., Science, 295 (2002) 1301-1306.
[2] Y. Kanehiro, K. Todo, M. Negishi, J. Fukuoka, W. Gan, T. Hikasa, Y. Kaga, M. Takemoto, M. 
Magari, X. Li, J.L. Manley, H. Ohmori, N. Kanayama, Activation-induced cytidine deaminase 
(AID)-dependent somatic hypermutation requires a splice isoform of the serine/arginine-rich (SR) 
protein SRSF1., Proc. Natl. Acad. Sci. U.S.A., 109 (2012) 1216-1221.
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Supplemental Table 1. Antibodies used for western blotting.
Antibody Clone or Cat No. Source
Primary antibody for western blotting
mouse anti-b-actin mAb sc-47778 Santa Cruz Biotechnology
mouse anti-AID mAb L7E7 Cell Signaling Technology
mouse anti-FLAG mAb M2 Sigma-Aldrich
goat anti-Hsp90 antibody AF3775 R&D Systems
rabbit anti-acetylhistone H4 antibody 06-866 Millipore
mouse anti-c-Myc mAb 4A6 Millipore
mouse anti-c-Myc mAb HRP MC045 Nakalai Tesque
Secondary antibody for western blotting
anti-rabbit IgG-HRP NA934V GE Healthcare
anti-mouse IgG-HRP NA931V GE Healthcare
donkey anti-goat IgG-HRP sc-2020 Santa Cruz Biotechnology
Secondary antibody for IP/western blotting
Mouse Trueblot Ultra anti-mouse Ig HRP 18-8817-31 Rockland
